Page 24 - Read Online
P. 24

Page 8 of 8                                                 Hafezi et al. Hepatoma Res 2018;4:16  I  http://dx.doi.org/10.20517/2394-5079.2018.55


               40.  Qasim W, Brunetto M, Gehring AJ, Xue SA, Schurich A, Khakpoor A, Zhan H, Ciccorossi P, Gilmour K, Cavallone D, Moriconi F,
                   Farzhenah F, Mazzoni A, Chan L, Morris E, Thrasher A, Maini MK, Bonino F, Stauss H, Bertoletti A. Immunotherapy of HCC metastases
                   with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. J Hepatol 2015;62:486-91.
               41.  Koh S, Shimasaki N, Suwanarusk R, Ho ZZ, Chia A, Banu N, Howland SW, Ong AS, Gehring AJ, Stauss H, Renia L, Sallberg M, Campana D,
                   Bertoletti A. A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus. Mol Ther
                   Nucleic Acids 2013;2:e114.
               42.  TCR-Redirected T Cells Infusions to Treat Patients With Recurrent Hepatocellular Carcinoma Post Liver Transplantation. In: ClinicalTrials.
                   gov, Identifier: NCT02719782.
               43.  Dahan R, Reiter Y. T-cell-receptor-like antibodies - generation, function and applications. Expert Rev Mol Med 2012;14:e6.
               44.  Sastry KS, Too CT, Kaur K, Gehring AJ, Low L, Javiad A, Pollicino T, Li L, Kennedy PT, Lopatin U, Macary PA, Bertoletti A. Targeting
                   hepatitis B virus-infected cells with a T-cell receptor-like antibody. J Virol 2011;85:1935-42.
               45.  Chang AY, Gejman RS, Brea EJ, Oh CY, Mathias MD, Pankov D, Casey E, Dao T, Scheinberg DA. Opportunities and challenges for TCR
                   mimic antibodies in cancer therapy. Expert Opin Biol Ther 2016;16:979-87.
               46.  Bassani-Sternberg M, Pletscher-Frankild S, Jensen LJ, Mann M. Mass spectrometry of human leukocyte antigen class I peptidomes reveals
                   strong effects of protein abundance and turnover on antigen presentation. Mol Cell Proteomics 2015;14:658-73.
               47.  Chiu YT, Wong JK, Choi SW, Sze KM, Ho DW, Chan LK, Lee JM, Man K, Cherny S, Yang WL, Wong CM, Sham PC, Ng IO. Novel pre-
                   mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinoma. J Hepatol 2016;64:1256-64.
               48.  Hino O, Kitagawa T, Koike K, Kobayashi M, Hara M, Mori W, Nakashima T, Hattori N, Sugano H. Detection of hepatitis B virus DNA in
                   hepatocellular carcinomas in Japan. Hepatology 1984;4:90-5.
               49.  Tokino T, Matsubara K. Chromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma. J Virol 1991;65:6761-4.
   19   20   21   22   23   24   25   26   27   28   29